Search research articles
Contact Us
Filters
Showing results (171-180 of 175) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 175 results.
The Journal of Pharmacology and Experimental Therapeutics
|
April 14, 2006
Carcinogen and anticancer drug transport by Mrp2 in vivo: studies using Mrp2 (Abcc2) knockout mice
M L H Vlaming, K Mohrmann, E Wagenaar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 4, 2003
Weekly oral paclitaxel as first-line treatment in patients with advanced gastric cancer
C M F Kruijtzer, H Boot, J H Beijnen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 19, 2022
Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients
P Aviles, R Altares, L van Andel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre
M T Huizing, G Giaccone, L J van Warmerdam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 2022
Therapeutic drug monitoring-based precision dosing of oral targeted therapies in oncology: a prospective multicenter study
S L Groenland, R A G van Eerden, K Westerdijk, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 175) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 175 results.
The Journal of Pharmacology and Experimental Therapeutics
|
April 14, 2006
Carcinogen and anticancer drug transport by Mrp2 in vivo: studies using Mrp2 (Abcc2) knockout mice
M L H Vlaming, K Mohrmann, E Wagenaar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 4, 2003
Weekly oral paclitaxel as first-line treatment in patients with advanced gastric cancer
C M F Kruijtzer, H Boot, J H Beijnen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 19, 2022
Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients
P Aviles, R Altares, L van Andel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre
M T Huizing, G Giaccone, L J van Warmerdam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 2022
Therapeutic drug monitoring-based precision dosing of oral targeted therapies in oncology: a prospective multicenter study
S L Groenland, R A G van Eerden, K Westerdijk, et al.
Page
of 18